TP53 and acute myeloid leukemia: p53 was found crucial for the increase of daunorubicin effect induced by CK2 inhibition in acute myeloid leukemia cells [38]; similarly, the sensitization to TNFα induced by CK2 blockade in glioblastoma cells is mediated by p53 function activation [39].